Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Chongqing Key Laboratory of Prevention and Treatment of Major Blinding Diseases, |
RCV004701248 | SCV005201079 | uncertain significance | Leber congenital amaurosis 14 | 2024-03-07 | criteria provided, single submitter | research | The variation LRAT:NM_004744.5:exon3:c.578G>T:p.R193I is of uncertain significance (PP1+PM2_Supporting+PM3_Supporting). Supportive pathogenic evidence PP1: The variation co-segregates with the disease in two affected family members. Supportive pathogenic evidence PM2_Supporting: The variation has not been found in the reference populations such as the 1000 Genomes Project, the China Genome Database, the Exome Aggregation Consortium (ExAC), and the Genome Aggregation Database (gnomAD). Supportive pathogenic evidence PM3_Supporting: The proband was found to have a homozygous variant. Upon querying public databases, mutations in the LRAT gene (OMIM:604863) can cause Leber congenital amaurosis 14 (LCA14) (OMIM:613341), Retinal dystrophy, early-onset severe (OMIM:613341), and Retinitis pigmentosa, juvenile (OMIM:613341). Leber congenital amaurosis 14, early-onset severe retinal dystrophy, and juvenile retinitis pigmentosa are primarily characterized by night blindness, decreased vision, extinguished electroretinogram (ERG), pale disc, nystagmus, photophobia, falling, rod-cone dystrophy, congenital blindness, pale optic disc, retinal dystrophy, and reduced amplitude of light and dark adaptation electroretinogram. |